Competing Interests Professor Melanie Davies has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Abbvie, Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma Regeneron, GSK and EktaH and as a speaker for AstraZeneca and Boehringer Ingelheim
Targeted Cellular Support If you are looking for more intensive support, a dosage of 500mg to 1,000mg (1 gram) may be appropriate
For gut-targeted applications leaky gut, IBD, gastric repair oral BPC-157 may actually be superior, because it delivers high concentrations directly to the target tissue
et al., Endocrine Reviews Its important to note: IGF-1 LR3 is not a fat-burner or testosterone mimic